Docetaxel NewsLatest News On Docetaxel ASPIRE trial explores survival benefits of adding chemotherapy to standard prostate cancer treatment5/5/2026 2:45 AM FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer3/10/2026 5:43 PM Tiny organism offers insight into neurological side effects of chemotherapy2/11/2026 5:09 PM Study offers new models for studying causes of chemo brain10/13/2025 12:29 PM New ASPIRE trial tests chemotherapy combination for advanced prostate cancer10/7/2025 2:54 AM Molecular profiling identifies prostate cancer patients who benefit most from chemotherapy8/28/2025 7:13 PM THP regimen achieves high response rates in HER2 positive breast cancer patients6/3/2025 3:24 AM Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC6/4/2024 7:51 PM Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge5/7/2024 10:42 AM Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels4/17/2024 5:08 PM
